KATE DEVARNEY

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

TITAN PHARMACEUTICALS INC

Filing Date Source Excerpt
2020-01-31 Kate DeVarney(5) - Includes 53,489 shares issuable upon exercise of outstanding options.
2020-05-22 Kate DeVarney(5) - Includes 53,489 shares issuable upon exercise of outstanding options.

Data sourced from SEC filings. Last updated: 2025-12-06